IFNG and neoplasm: While tumor-primed NK cells display augmented direct cytotoxicity against malignant cells, CIML-NK cells exhibit enhanced cytokine secretion, like IFN-γ, prolonged survival, and increased proliferative capacity, making them particularly effective in relapsed/refractory hematological malignancies [118].